http://orcid.org/0000-0003-4533-7937
References
- Harris AM, Hicks LA, Qaseem A. High value care task force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016;164:425–434.
- Clark TW, Medina MJ, Batham S, et al. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect. 2014;69(5):507–515.
- Jung HS, Kang BJ, Ra SW, et al. Elucidation of bacterial pneumonia-causing pathogens in patients with respiratory viral infection. Tuberc Respir Dis. 2017;80(4):358–367.
- Creer DD, Dilworth JP, Gillespie SH, et al. Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax. 2005;61(1):75–79.
- Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Physician. 2010;82(11):1345–1350.
- Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;11:CD001831.
- Park MJ, Rhee CK, Kim YH, et al. Efficacy and safety of HL301 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a phase 2, randomized, double-blind, placebo-controlled, multicenter study. Curr Med Res Opin. 2017;33(5):919–925.
- Yoon SW, Park MJ, Rhee CK, et al. HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebo controlled, multicenter study. Korean J Intern Med. [cited 2019 Apr 9]. DOI:10.3904/kjim.2018.181
- Roh GS, Seo SW, Yeo S, et al. Efficacy of a traditional Korean medicine, Chung-Sang-Bo-Ha-Tang, in a murine model of chronic asthma. Int Immunopharmacol. 2005;5(2):427–436.
- Lee H, Kim Y, Kim HJ, et al. PM014, attenuates lung inflammation in a murine model of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2012;2012:769830.
- Jung KH, Choi HL, Park S, et al. The effects of the standardized herbal formula PM014 on pulmonary inflammation and airway responsiveness in a murine model of cockroach allergen-induced asthma. J Ethnopharmacol. 2014;155(1):113–122.
- Jung KH, Haam KK, Park S, et al. The standardized herbal formula, PM014, ameliorated cigarette smoke-induced lung inflammation in a murine model of chronic obstructive pulmonary disease. BMC Complement Altern Med. 2013;13(1):219.
- Chung HS, Lee H, Bae H. Thirteen-week study of PM014 subchronic oral toxicity in rats. Based Complement Alternat Med. 2014;2014:189673.
- Careddu D, Pettenazzo A. Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children. IJGM. 2018;11:91–98.
- Brendler T, van Wyk BE. A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). J Ethnopharmacol. 2008;119(3):420–433.
- Helfer M, Koppensteiner H, Schneider M, et al. The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PLoS One. 2014;9(1):e87487.
- Moyo M, van Staden J. Medicinal properties and conservation of Pelargonium sidoides DC. J Ethnopharmacol. 2014;152(2):243–255.
- Timmer A, Günther J, Motschall E, et al. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013;10:CD006323.